William Catalona

Nov 20, 2024 | jamanetwork.com | Stacy Loeb |Matthew R. Cooperberg |William Catalona

Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020 Active surveillance and watchful waiting, periods of observation rather than early treatment, are considered optimal initial management strategies for individuals with nonaggressive prostate cancer.1 A recent surveillance study found low risks of metastasis (1.4%) and cancer mortality (0.1%) with active surveillance in individuals with primarily low–risk prostate cancer, typically defined as the lowest...

Nov 29, 2023 | cancernetwork.com | William Catalona

Research into genetic testing as a tool for localized diagnosis is still in its early days across most cancer types, and prostate cancer is no exception, according to William J. Catalona, MD.